New publication alert!
@uhn.ca's Dr. Viswanathan leads international experts on #MesenchymalStromalCells mechanism of action. Identifying research gaps and future directions will help boost the safety and efficacy of MSCs for conditions like #Arthritis.
🔗: www.isct-cytotherapy.org/article/S146...
@uhn.ca's Dr. Viswanathan leads international experts on #MesenchymalStromalCells mechanism of action. Identifying research gaps and future directions will help boost the safety and efficacy of MSCs for conditions like #Arthritis.
🔗: www.isct-cytotherapy.org/article/S146...
Fate and Function of Exogenously Administered MSCs: Current Insights and Future Directions
The in vivo fate of mesenchymal stromal cells (MSCs), including their clearance, interaction
with host tissues, and persistence, remains incompletely understood following systemic
or local clinical ad...
www.isct-cytotherapy.org
December 18, 2025 at 4:18 PM
New publication alert!
@uhn.ca's Dr. Viswanathan leads international experts on #MesenchymalStromalCells mechanism of action. Identifying research gaps and future directions will help boost the safety and efficacy of MSCs for conditions like #Arthritis.
🔗: www.isct-cytotherapy.org/article/S146...
@uhn.ca's Dr. Viswanathan leads international experts on #MesenchymalStromalCells mechanism of action. Identifying research gaps and future directions will help boost the safety and efficacy of MSCs for conditions like #Arthritis.
🔗: www.isct-cytotherapy.org/article/S146...
Human pancreatic #MesenchymalStromalCells express islet-protective ANXA1 and there are more MSCs around insulin-containing islets in #T1D. #MSC therapy may be most effective for individuals ≥13 years at diagnosis, where MSCs can better survive link.springer.com/article/10.1... 🔓
Characterisation of human pancreatic mesenchymal stromal cells in type 1 diabetes - Diabetologia
Aims/hypothesis Culture-expanded mesenchymal stromal cells (MSCs) reduce immune cell activation and improve islet functional survival. However, little is known about human pancreatic MSCs (pMSCs) in h...
link.springer.com
December 31, 2025 at 2:11 PM
Human pancreatic #MesenchymalStromalCells express islet-protective ANXA1 and there are more MSCs around insulin-containing islets in #T1D. #MSC therapy may be most effective for individuals ≥13 years at diagnosis, where MSCs can better survive link.springer.com/article/10.1... 🔓
Can #MesenchymalStromalCells treat #CLAD? And how does it inform the literature if they don't?
Today on #JHLTThePodcast, we talk to Daniel Chambers of Prince Charles Hospital about the ASSIST-CLAD study and what it reveals about new onset CLAD in #LungTx patients.
#pulmsky #transplantsky #medsky
Today on #JHLTThePodcast, we talk to Daniel Chambers of Prince Charles Hospital about the ASSIST-CLAD study and what it reveals about new onset CLAD in #LungTx patients.
#pulmsky #transplantsky #medsky
The ASSIST-CLAD Study on JHLT the Podcast
Daniel Chambers of the The Prince Charles Hospital in Brisbane, Australia is the guest on the JHLT podcast, discussing what the ASSIST-CLAD study revealed about treatment for new-onset CLAD.
www.ishlt.org
August 19, 2026 at 3:57 PM
Can #MesenchymalStromalCells treat #CLAD? And how does it inform the literature if they don't?
Today on #JHLTThePodcast, we talk to Daniel Chambers of Prince Charles Hospital about the ASSIST-CLAD study and what it reveals about new onset CLAD in #LungTx patients.
#pulmsky #transplantsky #medsky
Today on #JHLTThePodcast, we talk to Daniel Chambers of Prince Charles Hospital about the ASSIST-CLAD study and what it reveals about new onset CLAD in #LungTx patients.
#pulmsky #transplantsky #medsky
[ainet] 미 FDA, 중간엽 기질세포(MSC) 첫 품질관리 기준 승인…세포치료 새 기준 제시
www.ainet.link/24742
www.ainet.link/24742
미 FDA, 중간엽 기질세포(MSC) 첫 품질관리 기준 승인…세포치료 새 기준 제시
톈진,중국2026년1월26일--미국식품의약국(FDA)이중간엽기질세포(MesenchymalStromalCells,MSC)를위한최초의전용품질관리기준을담은디바이스마스터파일(DeviceMaste
www.ainet.link
January 26, 2026 at 1:14 AM
[ainet] 미 FDA, 중간엽 기질세포(MSC) 첫 품질관리 기준 승인…세포치료 새 기준 제시
www.ainet.link/24742
www.ainet.link/24742
#fbf #science In this study #mesenchymalstromalcells from different sources and administered by different routes demonstrated distinct efficacy in reducing lung #inflammation and #remodeling in a model of #emphysema 👨🔬🫁🧫🔬💊
#lungdisease #inflammation #celltherapy
pubmed.ncbi.nlm.nih.gov/25272959/
#lungdisease #inflammation #celltherapy
pubmed.ncbi.nlm.nih.gov/25272959/
February 16, 2024 at 6:25 AM
#fbf #science In this study #mesenchymalstromalcells from different sources and administered by different routes demonstrated distinct efficacy in reducing lung #inflammation and #remodeling in a model of #emphysema 👨🔬🫁🧫🔬💊
#lungdisease #inflammation #celltherapy
pubmed.ncbi.nlm.nih.gov/25272959/
#lungdisease #inflammation #celltherapy
pubmed.ncbi.nlm.nih.gov/25272959/